ALPS Medical Breakthroughs ETF (ARCA: SBIO)
Ticker | Name | Share % | |
---|---|---|---|
PCVX | Vaxcyte Inc | 5.18% | |
CERE | Cerevel Therapeutics Holdings Inc. | 5.04% | |
VKTX | Viking Therapeutics Inc Com | 4.45% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 4.30% | |
SMMT | Summit Therapeutics Plc Spon Adr | 4.14% | |
IE | Alkermes Plc | 2.67% | |
AXSM | Axsome Therapeutics, Inc. | 2.37% | |
CRNX | Crinetics Pharmaceuticals Inc Com | 2.36% | |
CORT | Corcept Therapeutics Inc | 2.13% | |
MRUS | Merus Nv | 2.10% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
SBIO follows a Small Cap Growth investment style.
The top holdings of SBIO include: PCVX (5.18%), CERE (5.04%), VKTX (4.45%), RVMD (4.3%), SMMT (4.14%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for SBIO is currently not available.